These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30911238)

  • 1. Plasma Neuropeptide-S Levels in Populations Diagnosed with Generalized Anxiety Disorder: A Controlled Study.
    Baykan H; Baykan Ö; Durmaz O; Kara H; Hişmioğullari AA; Karlidere T
    Noro Psikiyatr Ars; 2019 Mar; 56(1):52-56. PubMed ID: 30911238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the relationship between plasma neuropeptide-S levels and clinical depression.
    Baykan H; Durmaz O; Baykan O; Sahin Can M; Kara H; Hismiogullari AA; Karlidere T
    Nord J Psychiatry; 2018 May; 72(4):292-295. PubMed ID: 29488437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and Erythropoietin Receptor Levels and Their Diagnostic Values in Drug-naïve Patients with Generalized Anxiety Disorder.
    Kurutas EB
    Clin Psychopharmacol Neurosci; 2023 May; 21(2):288-295. PubMed ID: 37119221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher baseline serum adiponectin predicts better treatment remission in patients with generalized anxiety disorder treated with escitalopram.
    Shen Z; Wang F; Cui L; Ren L; Hong X; Yuan Y; Shen X
    Ann Palliat Med; 2021 Jul; 10(7):7634-7643. PubMed ID: 34353051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson's disease.
    Kummer A; Cardoso F; Teixeira AL
    Arq Neuropsiquiatr; 2010 Aug; 68(4):495-501. PubMed ID: 20730299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
    Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of interleukin-2 and interleukin-10 with the pathophysiology and development of generalized anxiety disorder: a case-control study.
    Sarmin N; Roknuzzaman ASM; Sarker R; -Or-Rashid M; Qusar MS; Bachar SC; Kabir ER; Islam MR; Al Mahmud Z
    BMC Psychiatry; 2024 Jun; 24(1):462. PubMed ID: 38902708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies.
    Gammans RE; Stringfellow JC; Hvizdos AJ; Seidehamel RJ; Cohn JB; Wilcox CS; Fabre LF; Pecknold JC; Smith WT; Rickels K
    Neuropsychobiology; 1992; 25(4):193-201. PubMed ID: 1454160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative Antidepressant Effect of Chamomile (
    Amsterdam JD; Li QS; Xie SX; Mao JJ
    J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
    [No Abstract]   [Full Text] [Related]  

  • 11. A multicomponent yoga-based, breath intervention program as an adjunctive treatment in patients suffering from generalized anxiety disorder with or without comorbidities.
    Katzman MA; Vermani M; Gerbarg PL; Brown RP; Iorio C; Davis M; Cameron C; Tsirgielis D
    Int J Yoga; 2012 Jan; 5(1):57-65. PubMed ID: 22346068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive transcranial magnetic stimulation for treatment of major depressive disorder with comorbid generalized anxiety disorder.
    White D; Tavakoli S
    Ann Clin Psychiatry; 2015 Aug; 27(3):192-6. PubMed ID: 26247218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Anxious Symptom Severity and Olfactory Impairment in Young Adults with Generalized Anxiety Disorder: A Case-Control Study.
    Chen X; Guo W; Yu L; Luo D; Xie L; Xu J
    Neuropsychiatr Dis Treat; 2021; 17():2877-2883. PubMed ID: 34522099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Neurotrophic Factor Levels are not Associated with the Severity of Depression: Prospective Pilot Study.
    Zorkina YA; Syunyakov TS; Abramova OV; Yunes RA; Pavlichenko AV; Pavlov KA; Khobta EB; Susloparova DA; Tsarapkin GY; Andreyuk DS; Danilenko VN; Gurina OI; Morozova AY
    Consort Psychiatr; 2021; 2(4):13-22. PubMed ID: 39045452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of G protein-coupled estrogen receptor 1 (GPER1) in drug-naive patients with generalized anxiety disorder.
    Fındıklı E; Camkurt MA; Karaaslan MF; Kurutas EB; Altun H; İzci F; Fındıklı HA; Kardas S
    Psychiatry Res; 2016 Oct; 244():312-6. PubMed ID: 27512921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients.
    Esser P; Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
    Psychooncology; 2018 Jun; 27(6):1509-1516. PubMed ID: 29473255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview and clinical presentation of generalized anxiety disorder.
    Rickels K; Rynn M
    Psychiatr Clin North Am; 2001 Mar; 24(1):1-17. PubMed ID: 11225502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    Carter NJ; McCormack PL
    CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.
    Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A
    Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating generalized anxiety disorder using complementary and alternative medicine.
    McPherson F; McGraw L
    Altern Ther Health Med; 2013; 19(5):45-50. PubMed ID: 23981404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.